top of page

Back to the Top

Team Members

Brian Chung

Brian Chung

VP Product

This is placeholder text. To change this content, double-click on the element and click Change Content.

Camilla Jones

Camilla Jones

Content Manager

This is placeholder text. To change this content, double-click on the element and click Change Content.

Kelly Parker

Kelly Parker

HR Representative

This is placeholder text. To change this content, double-click on the element and click Change Content.

Marcus Harris

Marcus Harris

Account Director

This is placeholder text. To change this content, double-click on the element and click Change Content.

Brad Grecco

Brad Grecco

Marketing Associate

This is placeholder text. To change this content, double-click on the element and click Change Content.

Ashley Amerson

Ashley Amerson

Product Manager

This is placeholder text. To change this content, double-click on the element and click Change Content.

Suhash Patel

Helvetica Light is an easy-to-read font, with tall and narrow letters, that works well on almost every site.

Charlotte Caine

Helvetica Light is an easy-to-read font, with tall and narrow letters, that works well on almost every site.

Jamie Tanzer

Helvetica Light is an easy-to-read font, with tall and narrow letters, that works well on almost every site.

Joanna Weng

Helvetica Light is an easy-to-read font, with tall and narrow letters, that works well on almost every site.

Joel Tamayo

Helvetica Light is an easy-to-read font, with tall and narrow letters, that works well on almost every site.

Faisal Khurshid

Helvetica Light is an easy-to-read font, with tall and narrow letters, that works well on almost every site.

Husnain

Helvetica Light is an easy-to-read font, with tall and narrow letters, that works well on almost every site.

Axiom Alumni

Axiom’s strength comes from its diverse, collaborative team. Members of the Axiom think tank leverage deep personal expertise in biochemistry, pharmaceuticals, clinical trial design, and life sciences consulting to drive thought leadership in oncology and rare diseases.

bottom of page